Friday, November 20, 2026
Biotech

Novartis Lifts Big Drug Sales Goal to $18 Billion

Novartis raised its peak sales targets to $18 billion as demand for its top medicines grows.

Novartis expects its top medicines to bring in more cash than planned. The Swiss drugmaker now targets $18 billion in peak sales for its biggest treatments.

Patients want more of the company's key drugs. Doctors prescribe them for heart health and blood cancer. Sales continue to climb across these markets.

Chief Executive Vas Narasimhan wants to show investors that this growth will last. Novartis narrowed its focus to pure drug creation in recent years. That shift helps the company build a steady pipeline of winners.

Strong drug sales keep pharmaceutical giants stable in shaky markets. When trusted treatments sell well, it gives the company cash to invent new cures.

Source: CNBC

#Biotech#Novartis#Healthcare#Pharma#Stocks

More from Biotech